MaxCyte (LON:MXCT) Stock Crosses Below 50-Day Moving Average – Time to Sell?

Shares of MaxCyte, Inc. (LON:MXCT) crossed below its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of GBX 0.83 and traded as low as GBX 0.69. MaxCyte shares last traded at GBX 0.74, with a volume of 1,512,852 shares traded.

MaxCyte Stock Performance

The company has a current ratio of 12.39, a quick ratio of 14.38 and a debt-to-equity ratio of 9.70. The company has a market cap of £791,119.68, a PE ratio of -0.02 and a beta of 1.13. The firm’s 50-day simple moving average is GBX 0.83 and its two-hundred day simple moving average is GBX 1.30.

MaxCyte Company Profile

MaxCyte is a leading cell-engineering company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and to support innovative, cell-based research. MaxCyte brings best-in-class technology paired with ongoing support designed to facilitate complex engineering of a wide variety of cells and payloads, with the aim of advancing new treatment options for patients. For over 20 years, MaxCyte has been perfecting the art of cell-engineering, venturing beyond today’s process to innovate tomorrow’s solutions.